About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gt(ROSA)26Sortm3(CAG-EYFP)Hze
targeted mutation 3, Hongkui Zeng
MGI:3809521
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
ht1
Gt(ROSA)26Sortm3(CAG-EYFP)Hze/Gt(ROSA)26Sor+ involves: 129S6/SvEvTac * C57BL/6NCr MGI:4436849
cn2
Gt(ROSA)26Sortm3(CAG-EYFP)Hze/Gt(ROSA)26Sor+
Hiratm1c(EUCOMM)Wtsi/Hiratm1d(EUCOMM)Wtsi
Tg(Myh6-cre)2182Mds/0
B6.Cg-Gt(ROSA)26Sortm3(CAG-EYFP)Hze Hiratm1c(EUCOMM)Wtsi/Hiratm1d(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds MGI:5823159
cn3
Gt(ROSA)26Sortm3(CAG-EYFP)Hze/Gt(ROSA)26Sor+
Stat5atm2Mam Stat5btm1Mam/Del(11Stat5a-Stat5b)1Mam
Tg(Mx1-cre)1Cgn/0
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA MGI:5544442


Genotype
MGI:4436849
ht1
Allelic
Composition
Gt(ROSA)26Sortm3(CAG-EYFP)Hze/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6NCr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm3(CAG-EYFP)Hze mutation (11 available); any Gt(ROSA)26Sor mutation (944 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice are viable and fertile; used for cre reporter expression analysis




Genotype
MGI:5823159
cn2
Allelic
Composition
Gt(ROSA)26Sortm3(CAG-EYFP)Hze/Gt(ROSA)26Sor+
Hiratm1c(EUCOMM)Wtsi/Hiratm1d(EUCOMM)Wtsi
Tg(Myh6-cre)2182Mds/0
Genetic
Background
B6.Cg-Gt(ROSA)26Sortm3(CAG-EYFP)Hze Hiratm1c(EUCOMM)Wtsi/Hiratm1d(EUCOMM)Wtsi Tg(Myh6-cre)2182Mds
Cell Lines EPD0181_1_A05
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm3(CAG-EYFP)Hze mutation (11 available); any Gt(ROSA)26Sor mutation (944 available)
Hiratm1c(EUCOMM)Wtsi mutation (1 available); any Hira mutation (74 available)
Hiratm1d(EUCOMM)Wtsi mutation (0 available); any Hira mutation (74 available)
Tg(Myh6-cre)2182Mds mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• hearts show re-expression of fetal cardiac genes
• however, heart development proceeds normally
• hypertrophic cardiomyocytes are seen in the right ventricle free wall as early as 15 days after birth
• however, aberrant proliferation of or apoptosis of cardiomyocytes is not seen and there is no evidence of increased DNA damage
• lesions contain degenerating cardiomyocytes
• hearts at 6 weeks and 6 months of age exhibit white surface scars localized to the subepicardial region of the ventricular free walls; lesions contain degenerating cardiomyocytes and a large degree of collagen deposition indicating focal replacement fibrosis localized to the subepicardial myocardium
• mice show increased arterial elastance at 6 months of age, which is a measure of arterial load
• the slope of the end-diastolic pressure-volume relationship, which describes diastolic function, is elevated
• however, no effect is seen on the slope of end-systolic pressure-volume relationship, which describes the maximal developed ventricular pressure at any given ventricular volume
• mice show decreased stroke work at 6 months
• at 6 months of age
• at 6 months of age
• mice exhibit increased dp/dtmax-end-diastolic volume, the relationship between peak rate of pressure rise and EDV, which describes ventricular contractile performance
• mice show an increase in diastolic myocardial stiffness

cellular
• levels of manganese superoxide dismutase are reduced in scar-containing free-wall right ventricle, but not in non-scarred regions, suggesting impaired response to oxidative stress
• however, only very minor increases in reactive oxygen species are seen, indicating that cardiomyocyte degeneration most likely is not caused by increased oxidative stress

muscle
• hypertrophic cardiomyocytes are seen in the right ventricle free wall as early as 15 days after birth
• however, aberrant proliferation of or apoptosis of cardiomyocytes is not seen and there is no evidence of increased DNA damage
• lesions contain degenerating cardiomyocytes
• mice exhibit increased dp/dtmax-end-diastolic volume, the relationship between peak rate of pressure rise and EDV, which describes ventricular contractile performance
• cardiomyocyte sarcolemmal integrity is compromised in focal subepicardial areas between 15 and 25 days after birth




Genotype
MGI:5544442
cn3
Allelic
Composition
Gt(ROSA)26Sortm3(CAG-EYFP)Hze/Gt(ROSA)26Sor+
Stat5atm2Mam Stat5btm1Mam/Del(11Stat5a-Stat5b)1Mam
Tg(Mx1-cre)1Cgn/0
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCr * CBA
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Del(11Stat5a-Stat5b)1Mam mutation (0 available); any Del(11Stat5a-Stat5b)1Mam mutation (0 available)
Gt(ROSA)26Sortm3(CAG-EYFP)Hze mutation (11 available); any Gt(ROSA)26Sor mutation (944 available)
Stat5atm2Mam mutation (1 available); any Stat5a mutation (48 available)
Stat5btm1Mam mutation (0 available); any Stat5b mutation (33 available)
Tg(Mx1-cre)1Cgn mutation (7 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hematopoietic system
• fewer IL9+ cells in IFN-alpha-treated mice following differentiation towards Th9 lineage

immune system
• fewer IL9+ cells in IFN-alpha-treated mice following differentiation towards Th9 lineage





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory